[fa icon="calendar'] August 20, 2016 / posted in Dr. Mark Bates, Nexeon
Company continues development with focus on field of bioelectronics
Lexington, KY, Aug 19, 2016 -- The Vascular Interventional Advances (“VIVA”) awarded one of its highest honor, the Leader In EndoVascular Education Award (“LIVE Award”), to Dr. Mark C. Bates of Nexeon M
[fa icon="calendar'] August 11, 2015 / posted in Dr. Mark Bates, Ron Conquest, Nexeon, Grants & Funding, Rosellini Scientific
DALLAS, Aug. 11, 2015 /PRNewswire-iReach/ -- Rosellini Scientific, LLC ("RS" or "the Company") an operational investment company, announced today that it received a Fast Track SBIR to develop
[fa icon="calendar'] March 9, 2015 / posted in Dr. Mark Bates
Dr. Mark Bates received the American Heart Association’s prestigious 2015 Heart of Gold Award during the association’s annual “Heart Ball” on Feb. 28 at the Charleston Marriott. Honorees are selected based on their career and contributions to cardiology and cardiac sci
[fa icon="calendar'] January 29, 2014 / posted in Dr. Mark Bates, Innovation
CHARLESTON, W.Va. -- Hurricane native Dr. Mark Bates was working as a disc jockey after high school when he developed his first invention. He wanted a laser light show for dances he worked. So he invented one.
More than 60 U.S.-issued and pending patents later, Bates be
[fa icon="calendar'] January 16, 2014 / posted in Dr. Mark Bates, WVU School of Medicine
Hurricane, West Virginia-native, renowned physician, inventor and successful medical device entrepreneur Mark Bates, M.D., will keynote the 4th Annual West Virginia Bioscience Summit, to take place January 28, 2014 at the Embassy Suites Hotel in Charleston, where he
[fa icon="calendar'] October 23, 2013 / posted in Dr. Mark Bates
[fa icon="calendar'] May 6, 2013 / posted in Dr. Mark Bates, University of Charleston
Source Article: The UC Talon
[fa icon="calendar'] January 28, 2009 / posted in Dr. Mark Bates, Stents, SurModics, Innovation
Agreement Represents Second Stent Development Collaboration Between SurModics and Nexeon MedSystems
EDEN PRAIRIE, Minn. & CHARLESTON, W. Va.--(BUSINESS WIRE)--SurModics, Inc. (Nasdaq: SRDX), a leading provider of drug delivery and surface modification technologies to t
[fa icon="calendar'] October 8, 2008 / posted in Dr. Mark Bates, Stents, Clinical Trials, WVU School of Medicine
New Class of Stent Could Offer Non-DES Solution to Restenosis and Late Stent Thrombosis
CHARLESTON, W.Va. & CARLSBAD, Calif.--(BUSINESS WIRE)--Nexeon MedSystems, Inc., a developer of medical technology for the treatment of cardiovascular disease, announced today that t
[fa icon="calendar'] August 7, 2007 / posted in Dr. Mark Bates, Interventional Cardiology, Nanotech, Carbon nanotube technology, Unidym
Pasadena, CA & Charleston, WV - Arrowhead Research Corporation and Paragon Intellectual Properties, LCC announced recently that Arrowhead's majority-owned subsidiary, Unidym Inc., has signed an exclusive license agreement with Paragon's majority-owned subsidiary, Nanot
Nexeon is a bioelectronics company developing and manufacturing medical devices and the software platforms that support the remote management of these devices.
[fa icon="phone"]
[fa icon="envelope"] [email protected]
[fa icon="home"] 1708 Jaggie Fox Way, Lexington KY 40511